These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2511231)
1. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease. Berger BW; Johnson RC J Am Acad Dermatol; 1989 Dec; 21(6):1188-91. PubMed ID: 2511231 [TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Hunfeld KP; Ruzic-Sabljic E; Norris DE; Kraiczy P; Strle F Antimicrob Agents Chemother; 2005 Apr; 49(4):1294-301. PubMed ID: 15793100 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Hunfeld KP; Brade V Wien Klin Wochenschr; 2006 Nov; 118(21-22):659-68. PubMed ID: 17160604 [TBL] [Abstract][Full Text] [Related]
5. Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. Arnez M; Ruzić-Sabljić E; Ahcan J; Radsel-Medvescek A; Pleterski-Rigler D; Strle F Pediatr Infect Dis J; 2001 Mar; 20(3):251-5. PubMed ID: 11303825 [TBL] [Abstract][Full Text] [Related]
6. Cultivation of Borrelia burgdorferi from the blood of two patients with erythema migrans lesions lacking extracutaneous signs and symptoms of Lyme disease. Berger BW; Johnson RC; Kodner C; Coleman L J Am Acad Dermatol; 1994 Jan; 30(1):48-51. PubMed ID: 8277030 [TBL] [Abstract][Full Text] [Related]
7. Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. Schmidt B; Muellegger RR; Stockenhuber C; Soyer HP; Hoedl S; Luger A; Kerl H J Clin Microbiol; 1996 Jun; 34(6):1359-63. PubMed ID: 8735081 [TBL] [Abstract][Full Text] [Related]
8. Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study. Nadelman RB; Nowakowski J; Forseter G; Bittker S; Cooper D; Goldberg N; McKenna D; Wormser GP Am J Med; 1993 Jun; 94(6):583-8. PubMed ID: 8506882 [TBL] [Abstract][Full Text] [Related]
9. Treatment failure in erythema migrans--a review. Weber K Infection; 1996; 24(1):73-5. PubMed ID: 8852475 [TBL] [Abstract][Full Text] [Related]
10. Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance. Hunfeld KP; Ruzić-Sabljić E; Norris DE; Kraiczy P; Strle F Int J Med Microbiol; 2006 May; 296 Suppl 40():233-41. PubMed ID: 16530006 [TBL] [Abstract][Full Text] [Related]
11. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans. Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452 [TBL] [Abstract][Full Text] [Related]
12. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Weber K; Wilske B; Preac-Mursic V; Thurmayr R Infection; 1993; 21(6):367-72. PubMed ID: 8132365 [TBL] [Abstract][Full Text] [Related]
13. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. Hansen K; Hovmark A; Lebech AM; Lebech K; Olsson I; Halkier-Sørensen L; Olsson E; Asbrink E Acta Derm Venereol; 1992 Aug; 72(4):297-300. PubMed ID: 1357894 [TBL] [Abstract][Full Text] [Related]
14. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients. Kuiper H; Cairo I; Van Dam A; De Jongh B; Ramselaar T; Spanjaard L; Dankert J Br J Dermatol; 1994 Apr; 130(4):466-72. PubMed ID: 8186111 [TBL] [Abstract][Full Text] [Related]
15. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis. Breier F; Kunz G; Klade H; Stanek G; Aberer E Infection; 1996; 24(1):69-72. PubMed ID: 8852474 [TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Glatz M; Golestani M; Kerl H; Müllegger RR Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202 [TBL] [Abstract][Full Text] [Related]
18. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in urine specimens of patients with erythema migrans lesions. Mercier G; Burckel A; Lucotte G Mol Cell Probes; 1997 Apr; 11(2):89-94. PubMed ID: 9160322 [TBL] [Abstract][Full Text] [Related]
19. [Penicillin V is the first choice in the treatment of erythema migrans]. Bennet L; Stiernstedt S; Berglund J; Hagberg L; Karlsson M; Olsson I; Ornstein K Lakartidningen; 2006 May 3-9; 103(18):1454; author reply 1455. PubMed ID: 16729462 [No Abstract] [Full Text] [Related]
20. [First-choice treatment for erythema migrans is still penicillin]. Eliassen KE; Lindbaek M; Berild D; Hjortdahl P; Fetveit A Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1681; author reply 1681. PubMed ID: 18704139 [No Abstract] [Full Text] [Related] [Next] [New Search]